{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:42:14Z","timestamp":1790253734252,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T00:00:00Z","timestamp":1308009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021037","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T17:02:20Z","timestamp":1308330140000},"page":"e21037","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2\u03b1 Accumulation and Promotes Migration and Invasion"],"prefix":"10.1371","volume":"6","author":[{"given":"Sunil","family":"Sudarshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthigayan","family":"Shanmugasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina B.","family":"Livi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine F.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen J.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Tien","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Zhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","author":"A Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma.","volume":"7","author":"JR Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer.","volume":"98","author":"V Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.","volume":"30","author":"IP Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.","volume":"8","author":"JS Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.","volume":"107","author":"AC Epstein","year":"2001","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.","volume":"292","author":"M Ivan","year":"2001","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.","volume":"292","author":"P Jaakkola","year":"2001","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF.","volume":"294","author":"RK Bruick","year":"2001","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gde.2006.12.006","article-title":"Hypoxia-inducible factors: central regulators of the tumor phenotype.","volume":"17","author":"JD Gordan","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-06-2510","article-title":"Pseudohypoxic pathways in renal cell carcinoma.","volume":"13","author":"G Bratslavsky","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref12","first-page":"5215","article-title":"Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.","volume":"61","author":"MS Wiesener","year":"2001","journal-title":"Cancer Res"},{"key":"ref13","first-page":"1526","article-title":"[Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].","volume":"86","author":"N Zhang","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumour suppression by the human von Hippel-Lindau gene product.","volume":"1","author":"O Iliopoulos","year":"1995","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.","volume":"1","author":"K Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","article-title":"The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.","volume":"1","author":"JK Maranchie","year":"2002","journal-title":"Cancer Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1074\/jbc.M611569200","article-title":"NAD(P)H oxidases regulate HIF-2alpha protein expression.","volume":"282","author":"K Block","year":"2007","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"34495","DOI":"10.1074\/jbc.C800170200","article-title":"Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.","volume":"283","author":"A Toschi","year":"2008","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-09-3022","article-title":"The efficacy of the novel dual PI3-kinase\/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma.","volume":"16","author":"DC Cho","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.","volume":"177","author":"RL Grubb 3rd","year":"2007","journal-title":"J Urol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.humpath.2006.10.011","article-title":"Conventional renal cancer in a patient with fumarate hydratase mutation.","volume":"38","author":"HJ Lehtonen","year":"2007","journal-title":"Hum Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2353\/ajpath.2010.090606","article-title":"The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin.","volume":"176","author":"K Block","year":"2010","journal-title":"The American journal of pathology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI38443","article-title":"HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice.","volume":"119","author":"WY Kim","year":"2009","journal-title":"The Journal of clinical investigation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jcp.2003.011767","article-title":"Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma.","volume":"57","author":"MR Morris","year":"2004","journal-title":"J Clin Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1158\/1078-0432.CCR-04-0175","article-title":"Promoter hypermethylation profile of kidney cancer.","volume":"10","author":"E Dulaimi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/onc.2010.193","article-title":"Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression.","volume":"29","author":"Z Chen","year":"2010","journal-title":"Oncogene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/MCB.00483-09","article-title":"Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.","volume":"29","author":"S Sudarshan","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molcel.2007.01.001","article-title":"RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.","volume":"25","author":"YV Liu","year":"2007","journal-title":"Molecular cell"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/hmg\/ddq305","article-title":"Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.","volume":"19","author":"L O'Flaherty","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1000328","DOI":"10.1371\/journal.pbio.1000328","article-title":"Fumarase: a mitochondrial metabolic enzyme and a cytosolic\/nuclear component of the DNA damage response.","volume":"8","author":"O Yogev","year":"2010","journal-title":"PLoS Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.cellsig.2006.01.020","article-title":"AKT can be activated in the nucleus.","volume":"18","author":"R Wang","year":"2006","journal-title":"Cell Signal"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.","volume":"69","author":"D Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.","volume":"287","author":"BE Baysal","year":"2000","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3.","volume":"26","author":"S Niemann","year":"2000","journal-title":"Nat Genet"},{"key":"ref35","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.","author":"KA Janeway","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.","volume":"1","author":"PL Dahia","year":"2005","journal-title":"PLoS Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e7033","DOI":"10.1371\/journal.pone.0007033","article-title":"Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.","volume":"4","author":"Y Chen","year":"2009","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1096\/fj.09-146928","article-title":"Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.","volume":"24","author":"B Costa","year":"2010","journal-title":"FASEB J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2867-7-13","article-title":"HIF-2alpha downregulation in the absence of functional VHL is not sufficient for renal cell differentiation.","volume":"7","author":"MD Hughes","year":"2007","journal-title":"Cancer cell international"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-4598-5-66","article-title":"Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.","volume":"5","author":"BL Petrella","year":"2006","journal-title":"Molecular cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.","volume":"25","author":"RR Raval","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.","volume":"1","author":"K Kondo","year":"2003","journal-title":"PLoS Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T15:33:39Z","timestamp":1588952019000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021037"}},"subtitle":[],"editor":[{"given":"Marcelo G.","family":"Bonini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,14]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021037","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,14]]}}}